Search

Your search keyword '"Drayson, Mark T"' showing total 1,199 results

Search Constraints

Start Over You searched for: Author "Drayson, Mark T" Remove constraint Author: "Drayson, Mark T"
1,199 results on '"Drayson, Mark T"'

Search Results

151. Independent Treatments Group Design

152. Intimate Partner Violence

153. Impaired Glucose Tolerance

154. Integrated Health Care

155. Interleukins, -1 (IL-1), -6 (IL-6), -18 (IL-18)

156. Illness Perceptions Questionnaire (IPQ-R)

157. Insulin-Dependent Diabetes Mellitus (IDDM)

158. Infertility-Related Stress

159. Immune Responses to Stress

160. Incremental Cost-Effectiveness Ratio (ICER)

161. Impulsive Behavior

162. Inheritance, Genetic

163. Involuntary Exposure to Tobacco Smoke

164. Internal and External Validity Issues

165. Idiopathic Raynaud’s Phenomenon

166. Individual Difference Factors

167. Illness Representation Model

168. Internet-Mediated Studies

169. Internet-Based Studies

170. Intrinsic Religiousness (Religiosity)

171. In Vitro Fertilization

172. Insulin Effectiveness

173. Independent Living

174. Incarcerated Youths

175. Illness Cognitions and Perceptions

176. Illness Fatigue

177. Interpersonal Stress or Conflict

178. Irritable Bowel Syndrome (IBS): Psychological Treatment

179. Institute of Medicine

180. In Vitro Fertilization, Assisted Reproductive Technology

181. Intracytoplasmic Sperm Injection

182. Integrated Behavioral Medicine Research, Practice, Policy

183. Inflammatory Bowel Disease

184. Insulin Resistance (IR) Syndrome

185. Intrusive Thoughts, Intrusiveness

186. Intima-Media Thickness (IMT)

187. Insulin-Producing Cell

189. Stratifying risk of infection and response to therapy in patients with myeloma: a prognostic study

190. Sensitive Detection of SARS-CoV-2–Specific Antibodies in Dried Blood Spot Samples

191. Copy number evolution and its relationship with patient outcome—an analysis of 178 matched presentation-relapse tumor pairs from the Myeloma XI trial

192. Serological responses to SARS-CoV-2 following non-hospitalised infection: clinical and ethnodemographic features associated with the magnitude of the antibody response

194. Impact of Etiological Cytogenetic Abnormalities on Immunoparesis and Progression-Free and Overall Survival in Newly Diagnosed Multiple Myeloma

195. Anti-bacterial antibodies in multiple myeloma patients at disease presentation, in response to therapy and in remission: implications for patient management

197. Clinical characteristics and outcomes of IgD myeloma: experience across UK national trials

198. High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma

200. Valproic acid disables the Nrf2 anti-oxidant response in acute myeloid leukaemia cells enhancing reactive oxygen species-mediated killing.

Catalog

Books, media, physical & digital resources